Telmiduce AM Tablet

11% OFF

Original price was: ₹76.41.Current price is: ₹68.00.

Telmiduce AM 40 mg/5 mg Tablet
Company: Macleods Pharmaceuticals Pvt Ltd
Salt Composition: Telmisartan 40mg + Amlodipine 5mg

10.0 tablets in 1 strip

Buy Now

Description

Telmiduce AM Tablet is a combination antihypertensive containing Telmisartan and Amlodipine.

  • Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that relaxes blood vessels to lower blood pressure and protect the heart and kidneys.

  • Amlodipine (5mg): A calcium channel blocker that relaxes blood vessels, improving blood flow and reducing the workload on the heart.

This combination provides enhanced blood pressure control, especially in patients not adequately controlled on monotherapy.


Uses

Telmiduce AM Tablet is prescribed for:

  • Hypertension (high blood pressure)

  • Reducing cardiovascular risk in patients with high blood pressure

  • Patients not adequately controlled on either Telmisartan or Amlodipine alone

  • Management of heart failure and kidney protection in selected cases


Advantages

  • Dual-action therapy for better blood pressure control

  • Reduces risk of stroke, heart attack, and kidney damage

  • Once-daily dosing improves patient compliance

  • Suitable for patients resistant to single-drug therapy


Possible Side Effects

Common side effects:

  • Dizziness, headache

  • Swelling of ankles or feet (edema)

  • Fatigue or flushing

  • Mild gastrointestinal discomfort

Rare but serious side effects:

  • Severe hypotension (very low blood pressure)

  • Hyperkalemia (high potassium levels)

  • Liver or kidney dysfunction

  • Allergic reactions (rash, swelling, difficulty breathing)


Precautions

  • Take exactly as prescribed, preferably at the same time daily

  • Avoid excessive potassium intake

  • Inform your doctor if you have kidney or liver disease

  • Pregnancy and breastfeeding: avoid use

  • Regular blood pressure, kidney, and electrolyte monitoring recommended

Leave a Reply

Your email address will not be published. Required fields are marked *